How to evaluate AI PHQ-9 vendors is the practical question that follows every PHQ-9 educational blog, every conference session on depression screening automation, and every conversation with a colleague who has already made the switch. Knowing that AI PHQ-9 screening exists, understanding that it improves completion rates and clinical workflows, and accepting that the paper process is no longer sustainable are all distinct steps from actually choosing a system and committing to a vendor. This guide provides eight specific questions that separate vendors who will deliver a functioning clinical workflow from those who will deliver a login and a support email.
Table of Contents
Key Takeaways
- The Integration Question Is the Most Important One: According to mdhub’s 2026 behavioral health practice management analysis, integration failure is the single most common reason practices abandon tools they have already purchased. The question is not whether a vendor claims to integrate with your EHR. It is whether the scored PHQ-9 report lands automatically in your existing workflow without a staff member touching it.
- A BAA Is Not Optional — It Is a Legal Prerequisite: Ensora Health’s 2025 guide to evaluating AI for therapy practices states clearly that if a vendor will not sign a Business Associate Agreement, you cannot use their tool. This is not a negotiating point. It is a compliance requirement that applies before any patient data passes through the system.
- The APA Released an AI Evaluation Checklist for Practitioners in 2024: Psychology Today’s 2025 analysis reports that the American Psychological Association released an AI evaluation checklist for practitioners integrating AI tools into their practice, covering clinical evidence, data privacy, and tool utility. This framework provides the clinical foundation for the evaluation questions in this guide.
- Question 9 Alert Protocol Must Be Verified, Not Assumed: Any vendor that cannot specify in writing exactly what happens when a patient endorses suicidal ideation during a pre-visit PHQ-9 has not built the protocol. The alert must reach clinical staff before the patient enters the room. How and through what channel must be documented before go-live.
- Implementation Timeline and Post-Go-Live Support Are Clinical Requirements, Not Commercial Preferences: AHIMA’s guide to evaluating healthcare AI vendors identifies implementation process and ongoing support as critical evaluation criteria alongside clinical validity. For a mental health clinic deploying PHQ-9 automation, who manages the configuration after go-live is as important as the technology itself.
Why Evaluating AI PHQ-9 Vendors Requires Different Questions Than General Healthcare AI
Evaluating an AI PHQ-9 vendor is not the same as evaluating a general healthcare AI tool. The stakes are different. The PHQ-9 screens for depression and suicidal ideation in a clinical population. The data it handles is among the most sensitive patient information in outpatient care. The workflow it sits in has direct implications for patient safety when Question 9 is endorsed.
Kyan Health’s 2026 analysis of AI mental health tool evaluation identifies five documented risk areas for AI in mental health settings: misinformation, failure to escalate in crises, lack of evidence-based practice, absence of regulatory compliance, and over-reliance replacing human care. Each of these maps directly to a specific evaluation question for an AI PHQ-9 vendor.
General healthcare AI evaluation frameworks ask about accuracy, interoperability, and cost. PHQ-9-specific evaluation must additionally ask about crisis escalation protocol, clinical validity of the specific instrument delivery format, and the exact documentation the system generates for both clinical and billing purposes.
The eight questions below are sequenced to identify disqualifying answers as early as possible in the evaluation process. Questions 1 and 3 are the two that most commonly disqualify vendors on the first call.
Question 1: Does the Scored Report Land Automatically in My Existing EHR Workflow?
This is the most important question in the evaluation and the one that most clearly separates a genuine PHQ-9 workflow from a digital version of the paper process.
Ask it exactly as written and listen for the specific answer. There are three possible responses:
Response A — The report lands automatically in your existing clinical workflow before the appointment begins. No staff member retrieves it. No data entry step exists. Your clinician sees it in the workflow they already use. This is the answer that indicates a real integration.
Response B — The report goes to a vendor dashboard that your team accesses separately. A staff member logs into the vendor platform, retrieves the score, and transfers it to the EHR manually or the clinician checks a separate application before each applicable session. This is not an integration. This is the paper process with a different medium.
Response C — The vendor asks which EHR you use before answering. This indicates that integration scope varies by EHR and that a meaningful conversation about compatibility needs to happen before the evaluation proceeds. As mdhub’s 2026 analysis notes, real-time bidirectional data flow is the 2026 standard. Any vendor still relying on manual exports, CSV imports, or periodic sync jobs is a red flag.
Follow-up question: does the vendor handle the EHR integration setup entirely, or does your team need to manage any technical configuration?
For a full breakdown of what integrated versus non-integrated PHQ-9 workflows look like in practice, see AI PHQ-9 EHR Integration: The Essential 2026 Guide.
Question 2: What Exactly Happens When a Patient Endorses Question 9?
Ask the vendor to walk you through the specific sequence of events when a patient responds with a score above zero on Question 9. Do not accept a general description of crisis capabilities. Ask for the specific protocol.
The answer must include: which staff member receives the alert, through which channel the alert arrives, how quickly after the patient submits the question the alert fires, what happens if no staff member is available to receive the alert, and how the event is documented.
The minimum acceptable answer is: an immediate alert to the designated clinical staff member through a channel they are actively monitoring, fired before the patient enters the consultation room, with full documentation of the trigger and the routing action.
Any answer that includes the word voicemail, the phrase the next morning, or a description of the alert appearing only in the vendor dashboard rather than in a channel the clinical staff member actively monitors is a disqualifying answer for a mental health or psychiatry practice.
The clinical and legal responsibilities this question creates are covered in full in PHQ-9 Question 9 and Suicidal Ideation: Clinical and Legal Responsibilities for Outpatient Clinics.
Question 3: Will You Sign a Business Associate Agreement Before Any Patient Data Moves?
This question has one acceptable answer: yes.
Ensora Health’s 2025 guide states that if a vendor will not sign a BAA, the tool cannot be used in a clinical setting. This is not a matter of vendor preference or negotiation. It is a legal requirement under HIPAA that applies before any protected health information passes through the vendor’s system.
Ask for the BAA before signing any contract. Read it specifically for: whether it covers all data types the system handles including voice responses, PHQ-9 scores, and patient identifiers; whether it specifies how long data is retained and under what conditions it is deleted; and whether it addresses the specific sensitivity of mental health data, which carries additional protections beyond standard PHQ in some states.
Psychology Today’s 2025 analysis notes that the APA’s AI evaluation checklist for practitioners specifically covers whether health data is encrypted, whether it abides by HIPAA regulations, and whether it is shared with third-party companies. All three of these questions should be answered explicitly in the BAA.
Question 4: Does the Scoring Documentation Support CPT 96127 Billing?
This question separates vendors who have built for clinical practice from those who have built for research or population health use cases.
CPT 96127 billing for PHQ-9 screening requires four documentation elements in the clinical note: the instrument name, the numerical score, a clinical interpretation, and an action plan. The vendor’s system should automatically generate the first three elements in a structured, timestamped format that lands in the clinical record before the appointment begins.
Ask the vendor to show you what the structured PHQ-9 report looks like in the EHR. Verify that it contains the instrument name labelled as PHQ-9, the total numerical score, the severity classification, and the individual item responses. Verify that the report is timestamped and associated with the patient record and visit date.
The clinician adds the action plan during the session. The other three elements should require no manual entry. A full breakdown of CPT 96127 billing requirements for psychiatry practices is in CPT 96127 Billing PHQ-9 Psychiatry: Complete Guide for Clinics in 2026.
Question 5: Who Configures the System and What Does the Implementation Timeline Look Like?
AHIMA’s guide to evaluating healthcare AI vendors identifies implementation process and timeline as a core evaluation criterion. For a mental health clinic, this question is particularly important because the configuration requirements go beyond basic software setup.
Ask: who builds the pre-visit delivery workflow, who configures the Question 9 alert routing, who customises the call scripts or interaction language for your patient population, who manages the EHR integration, and who briefs your clinical staff before go-live.
Each of these steps requires either vendor involvement or internal technical resources. If the vendor delivers a login and a documentation portal and expects your team to configure the system, the implementation burden on your clinic is significant. If the vendor handles every configuration step and delivers a fully operational system, your team’s only pre-launch requirement is a briefing on the Question 9 protocol.
A realistic timeline for a properly configured AI PHQ-9 deployment is days to two weeks from contract signature to go-live. A vendor who quotes months or who requires your IT team to manage EHR integration is either not purpose-built for outpatient mental health or is not a good operational fit for a small to mid-size practice.
Question 6: Who Manages the System After Go-Live?
This is the question that most clinic owners forget to ask during the evaluation and most commonly wish they had asked after signing.
After the system goes live, two things will inevitably happen: something will need to be changed, and something will not work as expected. The clinic’s patient population will change, new clinicians will join, the EHR will update, or the Question 9 routing protocol will need to be adjusted. Ask who makes those changes and on what timeline.
The minimum acceptable answer is: the vendor manages all post-go-live configuration changes, monitors system performance, and responds to issues within a defined timeframe. Any answer that places configuration responsibility on the clinic’s team after go-live creates ongoing operational burden that was not present before deployment.
This is also the question that reveals whether the vendor relationship is transactional or a genuine ongoing partnership. A vendor who quotes a monthly or performance-based fee structure and monitors the system proactively is aligned with clinic outcomes. A vendor who provides a login and a support ticket system is not.
Question 7: Can the Screening Interval Rules Be Set by Patient Score?
Evidence-based PHQ-9 screening frequency guidelines require different intervals for different patient populations: every 2 to 4 weeks during active treatment, every 4 months for ongoing patients scoring 10 or above, and annually for stable patients scoring 9 or below. These intervals are not fixed calendar schedules. They are score-dependent rules.
Ask the vendor whether the system can automatically apply screening interval rules based on each patient’s most recent PHQ-9 score. A system that can only send PHQ-9 links on a fixed calendar schedule does not support measurement-based care. A system that applies score-based interval rules automatically means no staff member needs to track which patient is due for PHQ-9 at which visit.
For a full breakdown of evidence-based PHQ-9 screening frequency guidelines, see PHQ-9 Screening Frequency Mental Health Clinics: Complete 2026 Guide.
Question 8: What Is the Pricing Model and What Does It Include?
PHQ-9 automation vendors use several different pricing models. Understanding which model applies and what is included determines whether the quoted price represents the total cost of deployment or a base price with significant additions.
The main pricing models in the market are:
Per-patient monthly fee: A recurring fee per active patient on the PHQ-9 programme. Predictable, scales with the practice, and aligns vendor incentives with patient volume.
Per-screening fee: A fee for each PHQ-9 administered. Low entry cost, but total cost scales with screening frequency. Can become expensive for practices with high-volume or frequent-interval screening programmes.
Flat monthly subscription: A fixed fee regardless of patient volume or screening frequency. Predictable, but may not scale well as the practice grows or may include volume caps that trigger additional fees.
Performance-based model: Fees tied to measurable outcomes such as completion rates or revenue recovered. Aligns vendor incentives directly with clinic results.
In all cases, clarify what is included: EHR integration setup, ongoing configuration, Question 9 alert management, clinical staff briefing, and post-go-live support. A quoted price that excludes EHR integration setup can increase significantly once integration costs are added.
What the Research Says
Three findings from clinical and industry research directly support a structured vendor evaluation approach for AI PHQ-9 systems.
Finding 1 – Integration failure is the single most common reason practices abandon tools they have already purchased. mdhub’s 2026 analysis identifies integration failure as the primary reason behavioral health practices discontinue AI tools after purchase. Practices that evaluate integration quality before signing avoid the most common and most costly deployment failure mode. The questions in this guide prioritise integration evaluation at the top of the sequence for this reason.
Finding 2 – The APA released a formal AI evaluation checklist for clinical practitioners in 2024. Psychology Today’s 2025 analysis confirms that the American Psychological Association responded to rapid AI adoption in clinical practice with a formal evaluation framework covering clinical evidence, data privacy, and tool utility. That framework is the professional standard against which AI tools in clinical mental health settings should be evaluated. Questions 1, 3, and 4 in this guide map directly onto the APA framework’s core criteria.
Finding 3 – AHIMA identifies implementation process and ongoing support as critical evaluation criteria alongside clinical validity. The American Health Information Management Association’s vendor evaluation guide explicitly lists implementation timeline, resource requirements, and post-deployment support alongside clinical accuracy and integration compatibility as non-negotiable evaluation criteria. Questions 5 and 6 in this guide reflect AHIMA’s framework directly.
The Two Questions That Disqualify a Vendor Immediately
Of the eight questions above, two produce answers that should end the evaluation immediately regardless of how compelling the vendor’s other responses are.
Immediate disqualifier 1 — The vendor will not sign a BAA before patient data moves. There is no clinical, legal, or ethical justification for proceeding. If a vendor declines to sign a BAA, the conversation is over. No price, no feature set, and no reference from another clinic changes this.
Immediate disqualifier 2 — The Question 9 alert goes to a voicemail, a next-morning queue, or only to the vendor dashboard. A system that does not deliver an immediate Question 9 alert to the designated clinical staff member before the patient enters the room is not configured for a mental health or psychiatry setting. The clinical and legal consequences of a missed Q9 flag are covered in PHQ-9 Question 9 and Suicidal Ideation: Clinical and Legal Responsibilities for Outpatient Clinics.
Every other question in this guide produces answers that require judgment. These two produce answers that require a clear line.
What This Means for Your Clinic in 2026
The decision to automate PHQ-9 screening is increasingly straightforward for mental health and psychiatry clinics in 2026. The psychometric evidence supports it. The operational evidence supports it. The billing case supports it. The access gap makes it a clinical priority.
The decision about which vendor to choose is where clinics consistently underinvest in evaluation time. A vendor whose integration produces a separate dashboard, whose Question 9 alert fires the next morning, and whose post-go-live support is a ticket system does not deliver the clinical workflow that makes PHQ-9 automation valuable. A vendor whose integration lands the report in the existing clinical workflow, whose Q9 alert reaches the right person before the patient enters the room, and whose team manages all configuration permanently delivers a different clinical infrastructure entirely.
MedLaunch AI Powered PHQ-9 Screening handles EHR integration, Question 9 alert configuration, scoring documentation for CPT 96127, and ongoing management as part of every deployment. Most clinics are fully live within days with no technical setup required from the clinical team.
FAQ
How do I evaluate AI PHQ-9 vendors before committing?
Start with two questions: does the scored report land automatically in your existing EHR workflow without a staff member retrieving it, and what exactly happens when a patient endorses Question 9. These two questions identify the most common integration failures and the most critical clinical safety requirement before any other evaluation criteria are applied. From there, verify the BAA, the CPT 96127 documentation format, the implementation timeline, and the post-go-live support model.
What should I look for in an AI PHQ-9 vendor’s EHR integration?
The integration should deliver a structured PHQ-9 report, including the instrument name, numerical score, severity classification, and individual item responses, automatically into your existing clinical workflow before the appointment begins. No staff member should need to retrieve the score from a separate vendor dashboard or manually transfer data between systems. Real-time, automatic delivery is the standard against which all integration claims should be evaluated.
Is a Business Associate Agreement required for AI PHQ-9 vendors?
Yes. A Business Associate Agreement is a legal requirement under HIPAA before any protected health information passes through a vendor’s system. PHQ-9 scores, patient identifiers, and voice responses captured during screening are all protected health information. A vendor that will not sign a BAA cannot be used in a clinical setting regardless of any other feature or capability.
Can AI PHQ-9 screening support CPT 96127 billing?
Yes, provided the system generates a structured, timestamped report containing the four elements CPT 96127 requires: the instrument name, the numerical score, a clinical interpretation, and a documentation field for the clinician’s action plan. The first three elements should be generated automatically. The clinician adds the action plan. A system that stores PHQ-9 scores as free-text notes rather than structured data does not reliably support CPT 96127 billing.
How long should AI PHQ-9 implementation take?
A properly configured AI PHQ-9 deployment should be operational within days to two weeks from contract signature. If a vendor quotes months, requires your IT team to manage EHR integration, or does not include clinical staff briefing as part of the implementation, the operational burden on your clinic is significant. With MedLaunch, most clinics are fully live within days with no technical setup required from the clinical team.
What pricing models do AI PHQ-9 vendors use?
The main models are per-patient monthly fee, per-screening fee, flat monthly subscription, and performance-based pricing tied to outcomes. In all cases, verify what is included: EHR integration setup, ongoing configuration management, Question 9 alert management, and post-go-live support. A quoted price that excludes integration setup can increase significantly once total deployment costs are included.
Conclusion
Evaluating AI PHQ-9 vendors correctly requires different questions than evaluating general healthcare software. The clinical population is vulnerable, the data is sensitive, and the workflow includes a patient safety component in the form of Question 9 that has no equivalent in most outpatient administrative tools. The eight questions in this guide are designed to identify disqualifying answers early, verify the clinical and compliance requirements that apply to any deployment in a mental health setting, and distinguish vendors who have built for outpatient mental health from those who have adapted a general tool for a clinical context it was not designed for.
Two answers disqualify a vendor immediately. A refusal to sign a BAA and a Question 9 alert that does not reach clinical staff before the patient enters the room. Every other answer requires judgment. Those two do not.
For a complete overview of how MedLaunch AI Powered PHQ-9 Screening handles EHR integration, Question 9 alerting, CPT 96127 documentation, and ongoing management, visit the solution page. For the next step after vendor selection, see How Long Does PHQ-9 Automation Take to Implement? A Realistic Week-by-Week Timeline.
